VRS in Elderly: Webinar Highlights Vaccination’s Role in Prevention

by Chief Editor

Summary

The recent Webinar "Respiratory Syncytial Virus (RSV) in Older Adults", organized by the Institute for Higher Health Training with Moderna’s collaboration, highlighted the significant impact of RSV in older adults, particularly those with chronic diseases, during the 2022-2023 season. In Spain, 63% of RSV-related hospitalizations were in adults over 65, with a 10.9% lethality rate in those over 80, similar to Covid-19. Therefore, vaccination is crucial to prevent RSV-related complications and reduce healthcare costs.

However, for nurses to autonomously administer these vaccines, a population-based strategy is needed, similar to the flu vaccine. Experts agreed that this strategy should focus on those over 65, especially those with chronic diseases. Currently, these vaccines are not included in the national vaccination schedule, making it difficult for patients to access them.

Nurses play a crucial role in this vaccination strategy, as they can administer vaccines during other seasonal vaccination campaigns, such as the flu vaccine. A study cited during the Webinar revealed that nurses prefer vaccines that offer complete, safe, long-lasting protection with no side effects, can be stored between 2-8°C without reconstitution, and can be co-administered with other vaccines.

In conclusion, promoting RSV vaccination in older adults is essential for individual health and strengthening the healthcare system. Nurses have a key role in education, administration, and follow-up of these vaccinations.

Title: The Covid-19 Vaccine for Adults Aged 65 and Over in Spain

The vaccination campaign against Covid-19 in Spain has been underway since December 2020, with a primary focus on protecting the most vulnerable populations, including adults aged 65 and over. This article will provide an overview of the Covid-19 vaccine for this age group in Spain, including the available vaccines, the vaccination process, and important considerations.

Available Vaccines and Eligibility

In Spain, the following vaccines have been approved for use and are currently being administered:

  1. Pfizer-BioNTech: A two-dose vaccine, with the second dose administered 21 days after the first. It has shown an efficiency of 95% against the virus.
  2. Moderna: Another two-dose vaccine, with the second dose given 28 days after the first. Its efficiency has been reported at 94.1%.
  3. AstraZeneca: This is a viral vector vaccine, administered in two doses, with an interval of 8 to 12 weeks. The vaccine has shown an average efficiency of 70%.
  4. Johnson & Johnson/Janssen: A single-dose viral vector vaccine, with an efficiency of 66% against the virus.
  5. Novavax: A two-dose protein subunit vaccine, with a reported efficiency of 89.3%. However, it has not yet been authorized for use in Spain at the time of writing.

All adults aged 65 and over in Spain are eligible to receive the vaccine. The pace of the vaccination campaign can vary depending on the availability of vaccines and the region where you live.

The Vaccination Process

The vaccination process typically follows these steps:

  1. Appointment: Vaccinations are administered by appointment only. You can make an appointment through your primary care doctor, the national health service website (if you’re eligible), or in some regions, through regional health service websites.
  2. First Dose: If you’re receiving a two-dose vaccine, the second dose appointment will be scheduled at the time of your first dose administration.
  3. Post-Vaccination: After getting the vaccine, you’ll be required to wait for a short period for observation before leaving. This is to ensure you don’t experience any immediate adverse reactions.

Important Considerations

  • Allergies: If you have severe allergies or a history of allergic reactions, it’s crucial to inform the healthcare professional administering the vaccine.
  • Underlying Health Conditions: While Covid-19 vaccines are generally safe, they may not be suitable for everyone, especially those with severe immunosuppression or allergies to any of the vaccine components. Always consult with your doctor.
  • After Vaccination: Even after vaccination, it’s essential to continue following safety measures such as wearing masks, practicing social distancing, and maintaining good hand hygiene to prevent the spread of the virus.
  • Side Effects: Like any vaccine, Covid-19 vaccines can cause side effects. Common ones include pain, redness or swelling at the injection site, fatigue, headache, muscle or joint pain, chills, fever, and nausea. These are usually mild to moderate and resolve within a few days.

The vaccination of adults aged 65 and over is a significant step towards ending the Covid-19 pandemic. It’s crucial for individuals in this age group to get vaccinated when it’s their turn, not only for their health but for the health of the wider community.

You may also like

Leave a Comment